Last reviewed · How we verify
NCT05434845
The Effect of Blood on the PC Ratio During Pregnancy
NA trial testing Blood draw in Proteinuria in Pregnancy in 20 participants. Status unknown.
19 December 2022
Quick facts
| Lead sponsor | Marshall University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 20 |
| Start date | 19 June 2022 |
| Primary completion | 19 December 2022 |
| Estimated completion | 19 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood draw — full drug profile →
Conditions studied
- Proteinuria in Pregnancy — all drugs for Proteinuria in Pregnancy →
Sponsor
Marshall University
Who can join
Adults 18 to 45, female only, with Proteinuria in Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine the effect if blood on the the protein to creatine (PC) ratio in pregnant patients by adding blood to urine samples.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05434845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood draw
Trials testing the same drug.
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
- NCT07252622 — Progesterone Levels and Frozen Embryo Transfer Outcomes · not yet recruiting
- NCT07382076 — Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population · active not recruiting
- NCT06011824 — A Study of Effect of Megakaryocytes and Platelets in Breast Cancer · completed
- NCT05912400 — Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1 · completed
Other recruiting trials for Proteinuria in Pregnancy
Currently open trials in the same condition.
- NCT06115122 — PEPPI Study: Identification of Women at Risk for Placental Dysfunction · recruiting
Other Marshall University trials
Trials by the same sponsor.
- NCT06294314 — Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace · recruiting
- NCT06116864 — Enchasing Polyp Detection: The Effect of Adding Polyp Detection Attachment Device to Computer Aid Detection System. · NA · unknown
- NCT05955040 — Treatment of Elevated Blood Pressures in Early Pregnancy · Phase 2 · terminated
- NCT05284084 — Prevention of Broncho-aspiration (BA) in Adult Subjects During Their ICU Stay · NA · completed
- NCT04748107 — Treatment of Severe Hypertension With ICG Directed Therapy · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05434845 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marshall University
- Last refreshed: 8 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05434845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing